Form 4: Humana Director David T. Feinberg Reports Stock Unit Transactions

Director David T. Feinberg reports acquisition of Humana stock units through director fees and dividend reinvestment.

Summary

• David T. Feinberg, a director at Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The report indicates the acquisition of Humana common stock units through various mechanisms.
• These include annual director's fees payable in stock units, conversion of cash fees into stock units, and reinvestment of dividend payments into stock units.
• Specifically, 51 restricted stock units were acquired on March 28, 2024, at a price of $348.4148 per unit.
• Feinberg also holds 380, 3, and 430 restricted stock units acquired through other means.
• These stock units are payable in Humana Inc. common stock on a 1-for-1 basis and are exempt under Rule 16b-3(d)(1).
• 430 of the restricted stock units vest on December 31, 2024.

Sentiment

Score: 6

Explanation: Neutral sentiment as the document is a standard regulatory filing detailing stock unit transactions related to director compensation.

Positives

• The director's continued investment in Humana stock units demonstrates confidence in the company's future.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they relate to director compensation and do not significantly alter the company's financial position.

Key Dates